Full-Time

Head of Acute Portfolio Market Access

Reimbursement and Policy, Kidney Care

Confirmed live in the last 24 hours

Baxter International

Baxter International

10,001+ employees

Provides essential medical products and services

Biotechnology
Healthcare

Compensation Overview

$168k - $231kAnnually

+ Bonus + Commission + Long-term Incentive

Expert

Highland Park, IL, USA

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Requirements
  • Proven experience of global market access, HTA, reimbursement and evidence generation
  • Experience of at least 2 out of the following: Health Economics and Outcomes Research, Health Technology Assessment, Market Access, Real World Evidence (RWE)
  • Minimum of 15 years in field of Health Economics and Market Access including global, in country and regional roles
  • Experienced in collaborating and publishing with KOLs
  • Advanced degree (MS, MPH, PhD) in health economics, HTA and or Statistics
Responsibilities
  • Lead HEMAR Strategy for the ACUTE portfolio
  • Execute strategies in focus geographies in collaboration with regional teams
  • Responsibility for economic evidence generation for payers and providers including building capability across the commercial (evidence-based selling) and Medical Affairs organization
  • Strategic partner for New Product Development (R&D) value proposition: Non-clinical stakeholder dimension, value-based pricing, target product profile (TPP)

Baxter International provides a wide range of medical products and services essential for healthcare. The company operates in several areas, including critical care, hospital care, nutritional care, renal care, and surgical care. Its products are used in various settings, from emergency rooms to home healthcare, helping to meet the needs of patients and healthcare professionals globally. Baxter develops, manufactures, and distributes medical devices, pharmaceuticals, and biotechnology products, generating revenue through sales to healthcare providers and institutions. A key aspect that sets Baxter apart from competitors is its recent acquisition of Hillrom, which enhances its ability to offer comprehensive healthcare solutions. The company's goal is to improve care outcomes and increase access to healthcare through continuous innovation and a focus on patient needs.

Company Stage

IPO

Total Funding

N/A

Headquarters

Deerfield, Illinois

Founded

1931

Simplify Jobs

Simplify's Take

What believers are saying

  • Baxter's investment in Medically Home aligns with the growing home healthcare market.
  • Rising demand for personalized medicine offers Baxter opportunities for targeted therapies.
  • Expansion in telehealth supports Baxter's integrated healthcare solutions strategy.

What critics are saying

  • Needle-free injection technology could disrupt Baxter's traditional injection-based therapies.
  • Shift to home healthcare may require Baxter to adapt its product offerings.
  • Growing digital health importance necessitates further investment from Baxter to stay competitive.

What makes Baxter International unique

  • Baxter's acquisition of Hillrom enhances its comprehensive healthcare solutions portfolio.
  • Strong focus on patient-centric innovation sets Baxter apart in the healthcare industry.
  • Baxter's partnerships, like with Ayogo, leverage digital health for improved patient outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Parental Leave

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Commuter Benefits

Mental Health Support